Enteroviral Meningoencephalitis after Anti‐CD20 (Rituximab) Treatment
Open Access
- 1 February 2003
- journal article
- case report
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 36 (3) , e47-e49
- https://doi.org/10.1086/345746
Abstract
Treatment with the chimeric anti-CD20 monoclonal antibody rituximab induces rapid and long-lasting depletion of circulating B cells. We report the ocKeywords
This publication has 11 references indexed in Scilit:
- Enterovirus meningitis in adults in 1999–2000 and evaluation of clinical managementJournal of Medical Virology, 2002
- CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell LymphomaNew England Journal of Medicine, 2002
- CHOP plus Rituximab — Balancing Facts and OpinionNew England Journal of Medicine, 2002
- Treatment of childhood autoimmune haemolytic anaemia with rituximabThe Lancet, 2001
- Inappropriate antidiuretic hormone secretion, abdominal pain and disseminated varicella-zoster virus infection: an unusual and fatal triad in a patient 13 months post Rituximab and autologous stem cell transplantationClinical and Laboratory Haematology, 2001
- Treatment of Potentially Life-Threatening Enterovirus Infections with PleconarilClinical Infectious Diseases, 2001
- ENTEROVIRAL MENINGOENCEPHALITIS IN X-LINKED AGAMMAGLOBULINEMIA: INTENSIVE IMMUNOGLOBULIN THERAPY AND SEQUENTIAL VIRAL DETECTION IN CEREBROSPINAL FLUID BY POLYMERASE CHAIN REACTIONThe Pediatric Infectious Disease Journal, 2000
- Pure red cell aplasia due to parvovirus B19 in a patient treated with rituximabBlood, 2000
- Chronic enteroviral meningoencephalitis in agammaglobulinemia: Case report and literature reviewJournal of Clinical Immunology, 1992
- Chronic ECHO type 5 virus meningoencephalitis in X‐linked hypogammaglobulinemiaNeurology, 1979